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PP-186 Evaluation of hydatid cyst manifestations in
patients admitted to a tertiary hospital in
Tehran, Iran, during a 20-year period
M. Amini1 *. 1Shahed University, Faculty of Medicine, Iran
Background: Hydatid cyst is one of the most important
and dangerous human and herbivore animal helminthic
disease. Infection is quite prevalent in Iran, however,
patients’ features and manifestations have not been
clariﬁed thoroughly, thus, in the present study we evaluated
Iranian patients with hydatid cyst referred to a tertiary
hospital in Tehran during a 20-year period (1984 2004).
Materials and Methods: For this descriptive study, initial
data including age, sex, clinical symptoms, cyst type, the
place of cyst replacement, diagnostic technique, laboratory
ﬁndings, treatment modalities and relapse were obtained
from patients medical ﬁles.
Results: Totally, 60 patients aged 4 70 years were entered,
of whom 32 (53.3%) were females and 28 (46.7%) were
males. House-wives (75%) and farmer men (42.8%) were
more commonly affected. In 80% of the cases cyst was
found in liver (lonely or with other organ involvement).
Echinococcous Granulosus was detected in all patients.
RUQ pain and cough and sputum were the most common
symptoms of liver and lung cysts, respectively. Totally, 20%
of patients referred with relapses, most of whom were
multivesicular.
Conclusion: Our results revealed that hydatid cyst in Iran is
more or less the same as other western societies, however,
a high rate of relapse in multivesicular cysts was noted.
PP-187 Investigation on anti-leishmanial effects of
artemisinin in comparison with glucantim on
Leishmania major in vitro
S. Nemati1,2, H. Nahrevanian2 *, A. Haniloo1,
M. Farahmand2, A. Fazaeli1. 1Zanjan University of Medical
Sciences of Iran, 2Pasteur Institute of Iran, Iran
Background: Cutaneous leishmaniasis (CL), a zoonotic
infection caused by L. major and L. tropica. This disease
is still one of the health problems in the world, region
and Iran. Although artemisinin (qinghaosu) is widely
used as anti-malarial agent, it is also demonstrated its
anti-promastigote activities and an inhibitory effects on
leishmania proliferation.
Methods: In this study, artemisinin was diluted in the
methanol and promastigotes of L. major were treated with
four concentrations (61.5, 125, 250, 500mM) of artemisinin
and compared with those treated with glucantim and
untreated groups. The number of promastogotes in each
well was counted using a haemocytometer slide at 24, 48,
72 hours after being harvested.
Result: Artemisinin inhibited the parasite proliferation at
doses of 250 and 500mM at 48 and 72 hours in culture
medium. The related doses of 61.5 and 125 mM presented the
same effect at 24, 48 and 72 hours of cultivation. Moreover,
glucantim inhibited parasite multiplication at doses of 125,
250 and 500mM at 48, 72 hours.
Conclusion: Artemisinin at concentration of 500mM is
strikingly potent against leishmania, inhibiting the growth
of L. major promastigotes after 72 hours.
PP-188 Efﬁcacy of Schistosoma mansoni Paramyosin
(Sm97) and fatty acid binding protein (Sm-FABP)
as a candidate vaccine against schistosomiasis
mansoni
T. Diab1 *, I. Aly1. 1Theodor Bilharz Research Institute,
Parasitology Dep., Egypt
Objective: To evaluate the efﬁcacy of Schistosoma mansoni
paramyosin (Sm97) and Fasciola gigantica fatty acid binding
protein (Fg-FABP) as potential candidate vaccines against
Schistosoma mansoni infection.
Methods: Swiss Albino mice were immunized intraperi-
toneally (IP) three times, 2-week intervals, with 100mg
of puriﬁed Sm97 (gr. 1) or Fg-FABP (gr. 2). Two weeks
later, immunized and control (gr. 3) mice groups were
infected with 80 S. mansoni cercariae via tail immersion
method. Eight weeks post-infection all mice groups were
sacriﬁced for subsequent assessment of parasitological and
immunological measurements.
Results: Immunization of mice with puriﬁed Sm97 and Sm-
FABP induced marked reduction in worm burden (44.1% &
60.5%), intestinal and hepatic egg loads (59.1% & 40.8%
for Sm97 and 37% & 69.3% for Sm-FABP), granuloma size
(61% and 43%) and number of granulomas (32.6 & 42%) when
compared to infected control group. Protective immunity in
mice was associated with high titers of speciﬁc anti-Sm97
IgG1 and IgG2 and anti-FABP IgG1, IgG2, IgG4 and IgM.
Conclusion: Puriﬁed Sm97 or Fg-FABP would be potential
candidate vaccines against schistosomiasis though Sm-FABP
had a better protective effect against schistosome infection
than Sm97.
PP-189 Evaluation of the anthelmintic effects of
artemether against experimental Schistosoma
mansoni infection in mice using different time
periods of treatment
I. Aly1 *, R. Kamel2, S. Mahmoud1, N. Madboly3. 1Theodor
Bilharz Research Institute, 2Women College for Arts,
Science and Education, 3Cairo University, Egypt
Background: This work was to evaluate the chemo
prophylactic effect of artemether on different S. mansoni
developmental stages.
Methods: Male albino mice were infected with 80±10 of
S. mansoni cercariae, and then classiﬁed into 7 groups
each of 10 mice. Infected-untreated mice (A), PZQ-treated
42 days PI in a dose 500mg/kg/b. wt. for two consecutive
days (B), whereas in groups (C, D, E, F and G) mice were
treated with artemether at ﬁve different time periods 7, 14,
21 and 45 days post infection and 2 days before infection,
respectively in a dose (50mg/kg/b.wt.). Parasitological and
histopathological criteria were employed.
Results: The results of the present study suggest that
i.m dose of 50mg/kg artemether at 7, 14 and 21
days PI were efﬁcacies against S. mansoni with total
worm reduction (73.10%, 77.43% and 87.15%, respectively).
Furthermore, there was a signiﬁcant decline (P< 0.001) in
the mean granuloma number as well as the mean granuloma
diameter.
Conclusion: It was concluded that artemether could be a
promising agent in the control of schistosomiasis mansoni;
also it has a potentiality in improving the hepatic lesions.
Furthermore, it is effective as a chemo prophylactic agent.
